Cibus, Inc. (CBUS) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
CBIS (CBUS) Q1 2026: $8M Expense Cut Accelerates Commercialization Path in Rice and Biofragrances
May 15, 2026
-
CBUS Q4 2025: $10M Cost Cuts Extend Runway as Regulatory Tailwinds Unlock $200M Rice Royalties
March 18, 2026
-
CBUS (CBUS) Q3 2025: Rice Trait Agreements Expand to 7 Million Acres, Unlocking $200M Royalty Path
November 14, 2025
-
CBUS (CBUS) Q2 2025: $200M Rice Royalty Path Drives Operational Refocus and Cash Discipline
August 14, 2025